1ÌýJuneÌý2023 Ìý Professor Leighton asked to speak as call for new AMR networks is launched Ìý Continue Reading
27ÌýAprilÌý2023 Ìý NAMRIP funding in 2017 and 2020 started the route to commercialize novel ureteric stents Ìý Continue Reading
5ÌýAprilÌý2023 Ìý Preventing bone infection in bone graft augmentation and impaction bone grafting Ìý Continue Reading
25ÌýFebruaryÌý2023 Ìý Integrating the 3-dimensional bioelectrospray cell culture model with a microfluidic platform to model real-time physiological changes Ìý Continue Reading
9ÌýFebruaryÌý2023 Ìý Research started by NAMRIP leads to large grants and spin-out company Ìý Continue Reading
25ÌýJanuaryÌý2023 Ìý Study indicates a high proportion of inappropriate use of antibiotics for treatment of simple acute cough in China, despite a series of antimicrobial stewardship guidelines released in China since 2011 Ìý Continue Reading
19ÌýJanuaryÌý2023 Ìý Targeting use of antibiotics in primary care through use of technology and better diagnostic assessment Ìý Continue Reading
1ÌýOctoberÌý2022 Ìý Route to possible new therapies for Neisseria gonorrhoeae infections published Ìý Continue Reading
6ÌýSeptemberÌý2022 Ìý Global-NAMRIP member Ravi Kant wins Bill and Melinda Gates Foundation award Ìý Continue Reading
14ÌýAprilÌý2022 Ìý Global-NAMRIP support helps Ugandan entrepreneur protect schools, clinics and refugee camps from typhoid and cholera Ìý Continue Reading
11ÌýAprilÌý2022 Ìý NAMRIP's 2020 early pandemic work featured in National Health Executive NHE Magazine Ìý Continue Reading
8ÌýMarchÌý2022 Ìý Outreach Funding win for Routes of Infection / Routes to Safety Project Ìý Continue Reading
v2.jpg)
